Experts: Negotiating Big Pharma’s Prices Won’t Stifle Innovation—They Don’t Use the Money to Innovate!

Lynn Parramore explains how physician-scientist Fred Ledley and economist William Lazonick debunked the arguments of “industry lobbyists vehemently oppose Medicare drug price negotiations”. Click HERE to read the article at www.ineteconomics.org.

Featured

Think Big Pharma Won’t Profiteer in the Race to Treat Coronavirus? Think Again.

“In a 2019 Gallup poll, Big Pharma ranked as the most disliked industry in America. Rosie Collington, a graduate student at the University of Copenhagen and a researcher at the Academic-Industry Research Network, knows why: She has studied how major insulin manufacturing…